Skip to main content
SpringerLink
Log in

Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Renal cell carcinoma (RCC) in which clear cells with papillary architecture are present is a difficult diagnostic challenge. The most common type, clear cell RCC, only rarely has papillary architecture. The second most common one, papillary RCC, only rarely contains clear cells. However, two recently described less-common types, clear cell papillary and Xp11 translocation RCC characteristically feature both papillary architecture and cells with clear cytoplasm. Accurate diagnosis has both prognostic and therapeutic implications. This study aims to highlight the helpful cytomorphologic and immunohistochemical features of each of these entities to enable reproducible classification. Sixty RCC cases with clear cells and papillary architecture were selected and classified according to The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia and graded according to The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma then stained for CK7, carbonic anhydrase IX (CA IX), α-methylacyl-CoA-racemase (AMACR) and TFE-3. The characteristic immunoprofile of Clear RCC is CK7-, AMACR-, CA IX+ and TFE3-, papillary RCC is CK7+, AMACR+, CAIX- and TFE3-, while for clear cell papillary RCC it is CK7+, AMACR-, CAIX+ and TFE3- and lastly Xp11translocation RCC is CK7-, AMACR+, CAIX- and TFE3+. Immunohistochemical staining for CA IX, CK7, AMACR and TFE3 comprises a concise panel for distinguishing RCC with papillary and clear pattern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Deng F, Melamed J (2012) Histologic variants of renal cell carcinoma: does tumor type influence outcome? Urol Clin N Am 39:119–132

    Article  Google Scholar 

  2. Zhanyong B, Priti L, Song L et al (2013) Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study. Ann Diagn Pathol 17:58–62

    Article  Google Scholar 

  3. Sean R, John N, Liang C et al (2013) Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol 26:697–708

    Article  Google Scholar 

  4. Hillary R, Guido M, Pedram A (2012) Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 136:391–399

    Article  Google Scholar 

  5. Walter B, Hartmann A, Hofstädter F et al (2012) Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Arch 460:343–352

    Article  CAS  PubMed  Google Scholar 

  6. Borislav A, Cinthia B (2014) Clear cell papillary renal cell carcinoma: incidence, morphological features, immunohistochemical profile, and biologic behavior: a single institution study. Pathol Res Pract 210:234–241

    Article  Google Scholar 

  7. Rajen G, Elizabeth G, Ximing J et al (2013) Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch Pathol Lab Med 137:467–480

    Article  Google Scholar 

  8. Park J, Lee C, Suh J et al (2012) Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas. Korean J Pathol 46:541–547

    Article  PubMed Central  PubMed  Google Scholar 

  9. Saba K, Özden T, Sümer B et al (2008) Diagnostic utility of cytokeratins 7, 10 and 20 in renal cell carcinoma and oncocytoma. Turk J Pathol 24:140–146

    Google Scholar 

  10. Michelle P, Amy Z, Zhanyong B (2013) Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics. Ann Diagn Pathol 17:437–440

    Article  Google Scholar 

  11. Elizabeth M, Musie G, Robert N et al (2010) Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. Am J Clin Pathol 134:873–879

    Article  Google Scholar 

  12. John RS, Brett D, John NE et al (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37:1209–1220

    Google Scholar 

  13. Brett D, John CC, Guido M et al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37(10):1490–1504

    Article  Google Scholar 

  14. Edge S, Byrd D, Compton C et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 479–489

    Google Scholar 

  15. Stephen M, Yonghong X, Yupu L et al (2011) Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24:1207–1220

    Article  Google Scholar 

  16. Brannon A, Haake S, Hacker K et al (2012) Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol 61:258–268

    Article  PubMed Central  PubMed  Google Scholar 

  17. Aydin H, Chen L, Cheng L et al (2010) Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34:608–1621

    Google Scholar 

  18. Duan L, Youseff R, Margulis V et al (2011) Clear cell papillary renal cell carcinoma: clinicopathologic, immunohistochemical, and molecular analysis. Mod Pathol 24:189–193

    Google Scholar 

  19. Brunelli M, Menestrina F, Segala D et al (2009) Renal cell carcinoma with prominent leiomyomatous proliferation appears not to be a variant of clear cell renal cell carcinoma. Mod Pathol 22:160–165

    Google Scholar 

  20. Shen S, Truong L, Scarpelli M et al (2012) Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med 136:410–417

    Article  PubMed  Google Scholar 

  21. Al-Ahmadie H, Alden D et al (2011) Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am J Surg Pathol 36:949–961

    Article  Google Scholar 

  22. Tickoo S, Reuter V (2011) Differential diagnosis of renal tumors with papillary architecture. Adv Anat Pathol 18:120–131

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The author declares that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, Faculty of Medicine, Tanta University, 25 Hamdy Gado street, Tanta, Egypt

    Hanan AlSaeid Alshenawy

Authors
  1. Hanan AlSaeid Alshenawy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanan AlSaeid Alshenawy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alshenawy, H.A. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features. Pathol. Oncol. Res. 21, 893–899 (2015). https://doi.org/10.1007/s12253-015-9898-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-015-9898-7

Keywords

Search

Navigation